Provider
Biologic Immunomodulators - FocusRx (For Pharmacy Benefits Only) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Search Results
Displaying 4071 - 4080 of 4134 results
Provider
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Self-Administered Oncology Agents - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Phenylketonuria - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026
Provider
Sensipar (cinacalcet) - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026
Provider
Thrombopoietin Receptor Agonists and Tavalisse - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jan 01, 2026